论文部分内容阅读
β-arrestins, ubiquitous cellular scaffolding proteins that act as signaling mediators of numerouscritical cellular pathways, are attractive therapeutic targets because they promotetumorigenesis in several tumor models.However, targeting scaffolding proteins with traditionalsmall molecule drugs has been challenging.